The development of β-adrenergic receptor antagonists for the treatment of heart failure: a paradigm for translational science.
Temple University School of Medicine, Chief Academic Officer, Temple University Health System, Philadelphia, PA 19140, USA. Arthur.feldman@tuhs.temple.edu
Arthur M
AM
Feldman
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000818:Animals; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D055808:Drug Discovery; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D009206:Myocardium / Q000378:metabolism*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D057170:Translational Research, Biomedical
D000319:Adrenergic beta-Antagonists; D002317:Cardiovascular Agents; D011943:Receptors, Adrenergic, beta